Vaccines could offer fresh hope against respiratory syncytial virus
Nature
27 September 2023
Mechael Eisenstein
Mask wearing, social distancing and other public-health measures put in place to thwart COVID-19 also kept other respiratory infections at bay. But by late 2022, most countries had dropped these protections — and with no vaccine available, respiratory syncytial virus (RSV) ran amok in children who hadn’t been exposed to the virus for the previous two years. In the United States alone, RSV-related hospitalizations tripled in November 2022 relative to the pre-pandemic levels three years before.
Read full article: https://www.nature.com/articles/d41586-023-02956-0